; (C) screening for blood glucose for known or suspected diabetics; (D) weight assessment of detainees younger than 12 years of age; (E) a physical examination; and (F) a risk assessment and the development of a plan for monitoring and care, as appropriate. (2) Prescription medication (A) In general The medical professional conducting the screening pursuant to subsection (b) shall— (i) review any prescribed medication that is in the detainee’s possession or that was confiscated by CBP upon arrival; and (ii) determine if such medication should be— (I) kept by the detainee for use during detention; (II) properly stored by CBP, with appropriate access for use during detention; or (III) maintained with the detained individual’s personal property. (B) Right to medication A detainee may not be denied the use of necessary and appropriate medication for the management of the detainee’s illness. (3) Rule of construction Nothing in this subsection may be construed as requiring detainees to disclose their medical status or history. (d) Timing (1) In general Except as provided in paragraph (2), the initial screening and medical assessment described in subsections (b) and (c) shall take place as soon as practicable, but not later than 12 hours after a detainee’s arrival at a CBP facility. (2) High priority individuals The initial screening and medical assessment referred to in paragraph (1) shall take place as soon as practicable, but not later than 6 hours after a detainee’s arrival at a CBP facility if the individual— (A) reasonably self-identifies as having a medical condition that requires prompt medical attention; or (B) is— (i) exhibiting signs of acute or potentially severe physical or mental illness, or otherwise has an acute or chronic physical or mental disability or illness; (ii) pregnant; (iii) a child (with priority given, as appropriate, to the youngest children)